인쇄하기
취소
|
The scheduled drug price cut on Inist Biopharmaceutical’s products is interrupted once again.
The Ministry of Health and Welfare(MOHW) announced the ‘Drug Insurance Benefits List and Upper Limit Price Table’ on the 5th.
In the announcement, the government informed suspension of execution on the Inist Biopharmaceutical’s 49 products.
Inist was founded after acquiring Dongwoo Pharm, an active ...